Get the Stockscreener App
17.84
1.59%
0.28
After Hours:
17.84
Caredx Inc stock is traded at $17.84, with a volume of 641.70K.
It is up +1.59% in the last 24 hours and down -7.32% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.56
Open:
$17.57
24h Volume:
641.70K
Relative Volume:
0.96
Market Cap:
$913.70M
Revenue:
$379.81M
Net Income/Loss:
$-21.35M
P/E Ratio:
-45.24
EPS:
-0.3943
Net Cash Flow:
$35.44M
1W Performance:
+1.36%
1M Performance:
-7.32%
6M Performance:
+18.46%
1Y Performance:
-9.03%
1-Day Range:
$17.20
$18.16
1-Week Range:
$16.86
$18.16
52-Week Range:
$10.96
$21.48
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
17.84 | 899.36M | 379.81M | -21.35M | 35.44M | -0.3943 |
TMO
Thermo Fisher Scientific Inc
|
490.29 | 177.61B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.10 | 134.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
570.21 | 46.06B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.20 | 31.66B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
301.92 | 29.61B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx, Inc. (CDNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
(CDNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
CareDx (CDNA) Launches AI-based Platform VANTx - Insider Monkey
10 Best Diagnostics and Research Stocks to Buy According to Analysts - Insider Monkey
If You Invested $1,000 in Caredx (CDNA) - Stock Titan
CareDx (CDNA) Q4 earnings miss estimates - MSN
CDNA,SPOK Options - Finviz
Stock Analysis: Should you avoid CareDx Inc stock right now2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
Trend Review: Should you avoid CareDx Inc stock right now2026 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
CareDx introduces VANTx AI platform for complex transplant datasets - MSN
Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx rebounds as draft LCD suggests no change in coverage - MSN
How The CareDx (CDNA) Story Is Shifting With CMS LCD Uncertainty And New Guidance - Yahoo Finance
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
Braidwell LP Makes New Investment in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC - MarketBeat
Prosight Management LP Grows Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA - MarketBeat
(CDNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Launches VANTx AI Solution for Advanced Transplant Data Analysis - Bitget
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets - Zacks Investment Research
CareDx reports positive data for AlloHeme in AML and MDS post HCT - MSN
CareDx wins preliminary court approval for derivative settlement - MSN
CDNA PE Ratio & Valuation, Is CDNA Overvalued - Intellectia AI
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference - MarketBeat
Paragon Associates & Paragon Associates II Joint Venture Buys 205,597 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
CareDx Q4 2025 earnings preview - MSN
CareDx launches AI platform for transplant research By Investing.com - Investing.com Australia
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks - TipRanks
CareDx launches AI platform for transplant research - Investing.com
CareDx (CDNA) Introduces VANTx: A Revolutionary AI Data Platform for Transplants - GuruFocus
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Business Wire
Royce & Associates LP Has $5.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
First Eagle Investment Management LLC Buys 96,123 Shares of CareDx, Inc. $CDNA - MarketBeat
ARK Investment Management LLC Buys 70,468 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Amova Asset Management Americas Inc. - MarketBeat
Caredex Stock Quote, Share Price, News and Analysis - Longbridge
(CDNA) Risk Channels and Responsive Allocation - Stock Traders Daily
CDNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CareDx Issues Inducement Grants With Stock Options and RSUs for New Employees - geneonline.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI) - The Globe and Mail
BTIG Raises CareDx (CDNA) Price Target to $26.00, Maintains Buy Rating | CDNA Stock News - GuruFocus
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC) - The Globe and Mail
CareDx (CDNA) Returns To Q4 Loss As Revenue Growth Tests Bullish Narratives - simplywall.st
BTIG raises CareDx stock price target to $26 on strong Q4 results - Investing.com Canada
CareDx, Inc Q4 2025 Earnings Call Summary - Yahoo Finance
BTIG raises CareDx stock price target to $26 on strong Q4 results By Investing.com - Investing.com South Africa
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
2.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):